Misfolded alpha-synuclein detection by RT-QuIC in dementia with lewy bodies: a systematic review and meta-analysis
Introduction: Dementia with Lewy Bodies (DLB) is the second most common cause of neurodegenerative dementia after Alzheimer’s disease (AD), but the field is still lacking a specific biomarker for its core pathology: alpha synuclein (α-syn). Realtime quaking induced conversion (RT-QuIC) has recently...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-05-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2023.1193458/full |
_version_ | 1797825450866638848 |
---|---|
author | Carmen Peña-Bautista Rakesh Kumar Rakesh Kumar Miguel Baquero Miguel Baquero Jan Johansson Consuelo Cháfer-Pericás Axel Abelein Daniel Ferreira |
author_facet | Carmen Peña-Bautista Rakesh Kumar Rakesh Kumar Miguel Baquero Miguel Baquero Jan Johansson Consuelo Cháfer-Pericás Axel Abelein Daniel Ferreira |
author_sort | Carmen Peña-Bautista |
collection | DOAJ |
description | Introduction: Dementia with Lewy Bodies (DLB) is the second most common cause of neurodegenerative dementia after Alzheimer’s disease (AD), but the field is still lacking a specific biomarker for its core pathology: alpha synuclein (α-syn). Realtime quaking induced conversion (RT-QuIC) has recently emerged as a strong biomarker candidate to detect misfolded α-syn in DLB. However, the variability in the parameters of the technique and the heterogeneity of DLB patients make the reproducibility of the results difficult. Here, we provide an overview of the state-of-the-art research of α-syn RT-QuIC in DLB focused on: (1) the capacity of α-syn RT-QuIC to discriminate DLB from controls, Parkinson’s disease (PD) and AD; (2) the capacity of α-syn RT-QuIC to identify prodromal stages of DLB; and (3) the influence of co-pathologies on α-syn RT-QuIC’s performance. We also assessed the influence of different factors, such as technical conditions (e.g., temperature, pH, shaking-rest cycles), sample type, and clinical diagnosis versus autopsy confirmation.Methods: We conducted a systematic review following the PRISMA guidelines in August 2022, without any limits in publication dates. Search terms were combinations of “RT-QuIC” and “Lewy Bodies,” “DLB” or “LBD”.Results: Our meta-analysis shows that α-syn RT-QuIC reaches very high diagnostic performance in discriminating DLB from both controls (pooled sensitivity and specificity of 0.94 and 0.96, respectively) and AD (pooled sensitivity and specificity of 0.95 and 0.88) and is promising for prodromal phases of DLB. However, the performance of α-syn RT-QuIC to discriminate DLB from PD is currently low due to low specificity (pooled sensitivity and specificity of 0.94 and 0.11). Our analysis showed that α-syn RT-QuIC’s performance is not substantially influenced by sample type or clinical diagnosis versus autopsy confirmation. Co-pathologies did not influence the performance of α-syn RT-QuIC, but the number of such studies is currently limited. We observed technical variability across published articles. However, we could not find a clear effect of technical variability on the reported results.Conclusion: There is currently enough evidence to test misfolded α-syn by RT-QuIC for clinical use. We anticipate that harmonization of protocols across centres and advances in standardization will facilitate the clinical establishment of misfolded α-syn detection by RT-QuIC. |
first_indexed | 2024-03-13T10:54:13Z |
format | Article |
id | doaj.art-489490a372ab4021b2a8b418020cff66 |
institution | Directory Open Access Journal |
issn | 2296-889X |
language | English |
last_indexed | 2024-03-13T10:54:13Z |
publishDate | 2023-05-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Molecular Biosciences |
spelling | doaj.art-489490a372ab4021b2a8b418020cff662023-05-17T05:29:07ZengFrontiers Media S.A.Frontiers in Molecular Biosciences2296-889X2023-05-011010.3389/fmolb.2023.11934581193458Misfolded alpha-synuclein detection by RT-QuIC in dementia with lewy bodies: a systematic review and meta-analysisCarmen Peña-Bautista0Rakesh Kumar1Rakesh Kumar2Miguel Baquero3Miguel Baquero4Jan Johansson5Consuelo Cháfer-Pericás6Axel Abelein7Daniel Ferreira8Alzheimer’s Disease Research Group, Health Research Institute La Fe, Avda de Fernando Abril Martorell, Valencia, SpainDepartment of Biosciences and Nutrition, Karolinska Institutet, Stockholm, SwedenDivision of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, SwedenAlzheimer’s Disease Research Group, Health Research Institute La Fe, Avda de Fernando Abril Martorell, Valencia, SpainNeurology Unit, University and Polytechnic Hospital La Fe, Valencia, SpainDepartment of Biosciences and Nutrition, Karolinska Institutet, Stockholm, SwedenAlzheimer’s Disease Research Group, Health Research Institute La Fe, Avda de Fernando Abril Martorell, Valencia, SpainDepartment of Biosciences and Nutrition, Karolinska Institutet, Stockholm, SwedenDivision of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, SwedenIntroduction: Dementia with Lewy Bodies (DLB) is the second most common cause of neurodegenerative dementia after Alzheimer’s disease (AD), but the field is still lacking a specific biomarker for its core pathology: alpha synuclein (α-syn). Realtime quaking induced conversion (RT-QuIC) has recently emerged as a strong biomarker candidate to detect misfolded α-syn in DLB. However, the variability in the parameters of the technique and the heterogeneity of DLB patients make the reproducibility of the results difficult. Here, we provide an overview of the state-of-the-art research of α-syn RT-QuIC in DLB focused on: (1) the capacity of α-syn RT-QuIC to discriminate DLB from controls, Parkinson’s disease (PD) and AD; (2) the capacity of α-syn RT-QuIC to identify prodromal stages of DLB; and (3) the influence of co-pathologies on α-syn RT-QuIC’s performance. We also assessed the influence of different factors, such as technical conditions (e.g., temperature, pH, shaking-rest cycles), sample type, and clinical diagnosis versus autopsy confirmation.Methods: We conducted a systematic review following the PRISMA guidelines in August 2022, without any limits in publication dates. Search terms were combinations of “RT-QuIC” and “Lewy Bodies,” “DLB” or “LBD”.Results: Our meta-analysis shows that α-syn RT-QuIC reaches very high diagnostic performance in discriminating DLB from both controls (pooled sensitivity and specificity of 0.94 and 0.96, respectively) and AD (pooled sensitivity and specificity of 0.95 and 0.88) and is promising for prodromal phases of DLB. However, the performance of α-syn RT-QuIC to discriminate DLB from PD is currently low due to low specificity (pooled sensitivity and specificity of 0.94 and 0.11). Our analysis showed that α-syn RT-QuIC’s performance is not substantially influenced by sample type or clinical diagnosis versus autopsy confirmation. Co-pathologies did not influence the performance of α-syn RT-QuIC, but the number of such studies is currently limited. We observed technical variability across published articles. However, we could not find a clear effect of technical variability on the reported results.Conclusion: There is currently enough evidence to test misfolded α-syn by RT-QuIC for clinical use. We anticipate that harmonization of protocols across centres and advances in standardization will facilitate the clinical establishment of misfolded α-syn detection by RT-QuIC.https://www.frontiersin.org/articles/10.3389/fmolb.2023.1193458/fulldementia with Lewy bodiesalpha-synucleinRT-QuICbiomarkerdiagnosiscopathologies |
spellingShingle | Carmen Peña-Bautista Rakesh Kumar Rakesh Kumar Miguel Baquero Miguel Baquero Jan Johansson Consuelo Cháfer-Pericás Axel Abelein Daniel Ferreira Misfolded alpha-synuclein detection by RT-QuIC in dementia with lewy bodies: a systematic review and meta-analysis Frontiers in Molecular Biosciences dementia with Lewy bodies alpha-synuclein RT-QuIC biomarker diagnosis copathologies |
title | Misfolded alpha-synuclein detection by RT-QuIC in dementia with lewy bodies: a systematic review and meta-analysis |
title_full | Misfolded alpha-synuclein detection by RT-QuIC in dementia with lewy bodies: a systematic review and meta-analysis |
title_fullStr | Misfolded alpha-synuclein detection by RT-QuIC in dementia with lewy bodies: a systematic review and meta-analysis |
title_full_unstemmed | Misfolded alpha-synuclein detection by RT-QuIC in dementia with lewy bodies: a systematic review and meta-analysis |
title_short | Misfolded alpha-synuclein detection by RT-QuIC in dementia with lewy bodies: a systematic review and meta-analysis |
title_sort | misfolded alpha synuclein detection by rt quic in dementia with lewy bodies a systematic review and meta analysis |
topic | dementia with Lewy bodies alpha-synuclein RT-QuIC biomarker diagnosis copathologies |
url | https://www.frontiersin.org/articles/10.3389/fmolb.2023.1193458/full |
work_keys_str_mv | AT carmenpenabautista misfoldedalphasynucleindetectionbyrtquicindementiawithlewybodiesasystematicreviewandmetaanalysis AT rakeshkumar misfoldedalphasynucleindetectionbyrtquicindementiawithlewybodiesasystematicreviewandmetaanalysis AT rakeshkumar misfoldedalphasynucleindetectionbyrtquicindementiawithlewybodiesasystematicreviewandmetaanalysis AT miguelbaquero misfoldedalphasynucleindetectionbyrtquicindementiawithlewybodiesasystematicreviewandmetaanalysis AT miguelbaquero misfoldedalphasynucleindetectionbyrtquicindementiawithlewybodiesasystematicreviewandmetaanalysis AT janjohansson misfoldedalphasynucleindetectionbyrtquicindementiawithlewybodiesasystematicreviewandmetaanalysis AT consuelochaferpericas misfoldedalphasynucleindetectionbyrtquicindementiawithlewybodiesasystematicreviewandmetaanalysis AT axelabelein misfoldedalphasynucleindetectionbyrtquicindementiawithlewybodiesasystematicreviewandmetaanalysis AT danielferreira misfoldedalphasynucleindetectionbyrtquicindementiawithlewybodiesasystematicreviewandmetaanalysis |